Researchers are increasingly using AI to accelerate the search for treatments for neurological conditions such as Alzheimer’s, Parkinson’s, and motor neurone disease (MND). By analysing large volumes of patient and biological data,

A new study co-led by investigators at UCLA has found a drug can reduce the risk of re-acquiring lung cancer, it was announced Sunday. Researchers at UCLA’s Health Jonsson Comprehensive Cancer Center discovered that cancer drug selpercatinib “can significantly reduce the risk of lung cancer returning in patients with a rare genetic subtype of early-stage

The targeted therapy sunvozertinib was more effective than standard platinum-based chemotherapy as a first-line treatment for patients with advanced non-small cell lung cancer (NSCLC) driven by EGFR exon 20 insertion mutations (EGFR exon20ins),

Modern psychiatry has long struggled with one brutal fact: the people most at risk of suicide often cannot wait weeks for therapy or antidepressants to work. Now, a new study suggests researchers may have found the first drug regimen capable of rapid and sustaining relief from suicidal thoughts across a broad group of patients.

A study co-led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center shows promising results for a drug that treats patients with a rare genetic type of early-stage lung cancer, researchers said Sunday.

MANCHESTER and LONDON, England — Alison Starkie spends her days tracking down people who need testing or treatment for hepatitis C, especially those who are unhoused or actively using drugs. Starkie,

A revolutionary daily tablet has demonstrated the ability to extend survival times twofold for patients suffering from the world's most lethal form of cancer, according to groundbreaking clinical trial findings unveiled at a major international oncology gathering.